{"id":"gastrectomy-chemotherapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Myelosuppression"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Surgical complications (anastomotic leak, infection)"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a multimodal treatment approach for gastric cancer that combines surgical resection of the stomach (gastrectomy) with perioperative or adjuvant chemotherapy. The chemotherapy component typically uses platinum-based and fluoropyrimidine agents to eliminate micrometastatic disease and improve overall survival beyond surgery alone.","oneSentence":"Gastrectomy combined with chemotherapy removes the primary gastric tumor while systemic chemotherapy targets residual and metastatic cancer cells.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:13:45.145Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Locally advanced gastric cancer"},{"name":"Gastric adenocarcinoma amenable to curative resection"}]},"trialDetails":[{"nctId":"NCT03876288","phase":"","title":"Gastroparesis Outcome Longitudinal Database Enrolled Numerically","status":"RECRUITING","sponsor":"University of Louisville","startDate":"2013-01-01","conditions":"Gastroparesis","enrollment":3000},{"nctId":"NCT05871099","phase":"PHASE3","title":"Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not","status":"RECRUITING","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2022-11-20","conditions":"Gastric Cancer","enrollment":616},{"nctId":"NCT07437716","phase":"NA","title":"Impact Of Laparoscopic Sleeve Gastrectomy On Obesity-Related Comorbidities In Patients Over 65 Years","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2023-01-01","conditions":"Laparascopic Sleeve Gastrectomy, Obesity & Overweight, Obesity Type 2 Diabetes Mellitus","enrollment":60},{"nctId":"NCT05753306","phase":"PHASE2","title":"Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-04-20","conditions":"Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Metastatic Malignant Neoplasm in the Peritoneum","enrollment":40},{"nctId":"NCT06254183","phase":"PHASE4","title":"Effect of Gabapentin on Kidney Function Following Laparoscopic Sleeve Gastrectomy(LSG)","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-12-01","conditions":"Acute Kidney Injury, Obesity (BMI > 35)","enrollment":90},{"nctId":"NCT07266025","phase":"PHASE2","title":"Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-01-30","conditions":"Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma, Mismatch Repair Deficient or MSI-High Solid Tumors","enrollment":30},{"nctId":"NCT06510010","phase":"PHASE2","title":"Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2024-12-31","conditions":"Chemotherapy Effect","enrollment":198},{"nctId":"NCT06468280","phase":"PHASE2","title":"Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2024-11-08","conditions":"Gastric Cancer, GastroEsophageal Cancer","enrollment":84},{"nctId":"NCT07353177","phase":"","title":"Effects of HIPEC on Postoperative Bowel Motility and Complications","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-04-20","conditions":"HIPEC, Gastro Intestinal Cancer, Adhesion Prevention","enrollment":193},{"nctId":"NCT07313579","phase":"","title":"Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer","status":"RECRUITING","sponsor":"Ukrainian Society of Clinical Oncology","startDate":"2025-12-01","conditions":"Gastric Cancer (GC), HIPEC, Peritoneal Metastases From Gastric Cancer","enrollment":200},{"nctId":"NCT07330063","phase":"PHASE2","title":"Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Totally Laparoscopic Radical Distal Gastrectomy","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2025-12-22","conditions":"Gastrectomy","enrollment":114},{"nctId":"NCT07328633","phase":"NA","title":"Prehabilitation Plus ERAS in Gastric Cancer Surgery","status":"COMPLETED","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2024-12-05","conditions":"Gastric Cancer (GC)","enrollment":136},{"nctId":"NCT07259473","phase":"PHASE2","title":"Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-01-31","conditions":"Gastric / Gastroesophageal Junction Adenocarcinoma, Mismatch Repair Deficient or MSI-High Solid Tumors, Immunotherapy","enrollment":15},{"nctId":"NCT03756961","phase":"NA","title":"Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery","status":"RECRUITING","sponsor":"Göteborg University","startDate":"2019-05-01","conditions":"Obesity, Pain, Postoperative","enrollment":220},{"nctId":"NCT07315035","phase":"PHASE2","title":"QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2026-01-01","conditions":"Gastric Cancer Stage III","enrollment":74},{"nctId":"NCT07139951","phase":"PHASE2","title":"Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Patients With Gastric and Gastroesophageal Junction Adenocarcinoma at High Risk of Peritoneal Recurrence","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2025-12-03","conditions":"Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8","enrollment":16},{"nctId":"NCT03042169","phase":"PHASE3","title":"Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2021-08-25","conditions":"Gastric Adenocarcinoma","enrollment":6},{"nctId":"NCT07058155","phase":"PHASE4","title":"Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-12-17","conditions":"Liver Cirrhoses, Portal Hypertension Related to Cirrhosis, Severe Obesity","enrollment":70},{"nctId":"NCT03013010","phase":"PHASE3","title":"PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy","status":"COMPLETED","sponsor":"Shanghai Cancer Hospital, China","startDate":"2016-12","conditions":"Stomach Neoplasm, GastroEsophageal Cancer, Adenocarcinoma","enrollment":204},{"nctId":"NCT07101666","phase":"PHASE2","title":"Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-01-31","conditions":"Gastric Cancer","enrollment":20},{"nctId":"NCT05508399","phase":"","title":"Biomarker Analysis of Tislelizumab Combined With Chemotherapy for Perioperative Treatment of G/GEJ Adenocarcinoma","status":"COMPLETED","sponsor":"Xijing Hospital","startDate":"2022-07-18","conditions":"Locally Advanced Gastric Adenocarcinoma, PD-1","enrollment":28},{"nctId":"NCT07257380","phase":"PHASE2","title":"Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-12-30","conditions":"Gastric / Gastroesophageal Junction Adenocarcinoma","enrollment":90},{"nctId":"NCT05507658","phase":"PHASE2","title":"Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma","status":"COMPLETED","sponsor":"Xijing Hospital","startDate":"2022-07-18","conditions":"Locally Advanced Gastric Adenocarcinoma","enrollment":28},{"nctId":"NCT07027969","phase":"PHASE4","title":"Metabolic Surgery for Atrial Fibrillation Elimination","status":"NOT_YET_RECRUITING","sponsor":"Ali Aminian","startDate":"2026-02-01","conditions":"Atrial Fibrillation, Obesity and Obesity-related Medical Conditions","enrollment":100},{"nctId":"NCT07243938","phase":"PHASE2","title":"Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)","status":"NOT_YET_RECRUITING","sponsor":"Tao Zhang","startDate":"2026-01-15","conditions":"Locally Advanced Rectal Cancer (LARC), Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (mCRC)","enrollment":70},{"nctId":"NCT03776487","phase":"PHASE2","title":"Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2019-01-07","conditions":"Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I Gastric Cancer AJCC v8","enrollment":32},{"nctId":"NCT05156762","phase":"NA","title":"Total Joint Arthroplasty (TJA) Weight Loss Study","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2022-10-03","conditions":"Osteoarthritis, Hip, Osteoarthritis, Knee, Obesity, Morbid","enrollment":3},{"nctId":"NCT07213115","phase":"","title":"Epidemiology and Treatment of Gastric Cancer","status":"COMPLETED","sponsor":"Medizinische Hochschule Brandenburg Theodor Fontane","startDate":"2000-01-01","conditions":"Gastric (Stomach) Cancer, Sex Difference","enrollment":8582},{"nctId":"NCT07183358","phase":"NA","title":"Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2025-09-20","conditions":"Stomach Neoplasms, Neoadjuvant Therapy","enrollment":90},{"nctId":"NCT07007182","phase":"PHASE2","title":"Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"Jinbo Yue","startDate":"2025-10-01","conditions":"Gastric Adenocarcinoma, Stomach Neoplasms","enrollment":54},{"nctId":"NCT02205047","phase":"PHASE2","title":"Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2015-07-15","conditions":"Malignant Neoplasm of Stomach, Malignant Neoplasm of Cardio-esophageal Junction of Stomach, Epidermal Growth Factor Receptor (EGFR) Protein Overexpression","enrollment":172},{"nctId":"NCT06732856","phase":"PHASE1, PHASE2","title":"A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-04-04","conditions":"Stomach Neoplasm, Gastric (Stomach) Cancer","enrollment":57},{"nctId":"NCT03348150","phase":"PHASE3","title":"Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2017-10-01","conditions":"Stomach Neoplasm, Peritoneal Carcinomatosis","enrollment":102},{"nctId":"NCT07056010","phase":"NA","title":"Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2024-11-25","conditions":"Gastric Cancer","enrollment":30},{"nctId":"NCT01815853","phase":"PHASE3","title":"Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2013-06","conditions":"Gastric Cancer","enrollment":620},{"nctId":"NCT06895447","phase":"PHASE2","title":"Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2024-11-14","conditions":"Gastric Cancers","enrollment":40},{"nctId":"NCT06728657","phase":"PHASE2","title":"Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma","status":"SUSPENDED","sponsor":"Fudan University","startDate":"2024-07-01","conditions":"Stomach Adenocarcinoma, Gastro-esophageal Junction Cancer","enrollment":68},{"nctId":"NCT05161572","phase":"PHASE2","title":"Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer","status":"TERMINATED","sponsor":"Fudan University","startDate":"2021-09-28","conditions":"Stomach Neoplasms, Esophagogastric Junction Disorder, Neoadjuvant Therapy","enrollment":6},{"nctId":"NCT07018063","phase":"PHASE2","title":"Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"zhoujing","startDate":"2025-10-01","conditions":"Gastric (Cardia, Body) Cancer, Stomach Adenocarcinoma, Locally Advanced","enrollment":35},{"nctId":"NCT06784765","phase":"NA","title":"Preventive Use of PIPAC in Locally Advanced Gastric Cancer.","status":"RECRUITING","sponsor":"National Research Oncology and Transplantology Center, Kazakhstan","startDate":"2025-01-15","conditions":"Gastric Cancer","enrollment":160},{"nctId":"NCT06028737","phase":"PHASE2, PHASE3","title":"Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer","status":"RECRUITING","sponsor":"Ukrainian Society of Clinical Oncology","startDate":"2025-03-25","conditions":"Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer","enrollment":150},{"nctId":"NCT05593458","phase":"PHASE3","title":"Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1","status":"RECRUITING","sponsor":"Zhejiang University","startDate":"2023-04-01","conditions":"Locally Advanced Gastric Carcinoma","enrollment":190},{"nctId":"NCT04180761","phase":"PHASE2","title":"Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer","status":"WITHDRAWN","sponsor":"University Hospital Tuebingen","startDate":"2019-11","conditions":"Gastric Neoplasms","enrollment":""},{"nctId":"NCT01924819","phase":"PHASE2, PHASE3","title":"Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Australasian Gastro-Intestinal Trials Group","startDate":"2009-09","conditions":"Gastric Cancer","enrollment":574},{"nctId":"NCT03092518","phase":"PHASE2","title":"Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-06-05","conditions":"Gastric Adenocarcinoma, Esophagogastric Junction, Gastric Cancer","enrollment":27},{"nctId":"NCT06055387","phase":"NA","title":"Frailty Assessment and Intervention in Elderly Patients with Gastric Cancer Receiving Gastrectomy and Adjuvant Chemotherapy","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2022-01-01","conditions":"Gastric Cancer","enrollment":300},{"nctId":"NCT06820047","phase":"","title":"Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2022-05-01","conditions":"Obesity and Obesity-related Medical Conditions","enrollment":190},{"nctId":"NCT06798376","phase":"","title":"Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2025-01-16","conditions":"Gastric Adenocarcinoma","enrollment":300},{"nctId":"NCT05180734","phase":"PHASE3","title":"PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai Junshi Bioscience Co., Ltd.","startDate":"2022-02-10","conditions":"Gastric or Esophagogastric Junction Adenocarcinoma","enrollment":878},{"nctId":"NCT04162665","phase":"PHASE2","title":"Pre-operative Adaptive Short Court Radiation Therapy in Gastric Cancer","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2020-02-14","conditions":"Gastric Adenocarcinoma","enrollment":4},{"nctId":"NCT04602572","phase":"","title":"Obesity and Oral Diseases in Adult Patients","status":"NOT_YET_RECRUITING","sponsor":"University of Bergen","startDate":"2025-09-01","conditions":"Obesity, Oral Diseases, Periodontitis","enrollment":400},{"nctId":"NCT04136769","phase":"NA","title":"Preoperative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer","status":"TERMINATED","sponsor":"Ulrich Ronellenfitsch, MD","startDate":"2020-02-07","conditions":"Pancreas Cancer","enrollment":3},{"nctId":"NCT02867839","phase":"PHASE3","title":"Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer","status":"TERMINATED","sponsor":"Peking University Cancer Hospital & Institute","startDate":"2017-04-24","conditions":"Gastric Cancer","enrollment":29},{"nctId":"NCT04883346","phase":"PHASE2","title":"Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2021-06-21","conditions":"Obesity, Status Post Sleeve Gastrectomy","enrollment":34},{"nctId":"NCT04937738","phase":"PHASE2","title":"Perioperative Chemotherapy in Gastric Cancer","status":"TERMINATED","sponsor":"Ukrainian Society of Clinical Oncology","startDate":"2021-07-21","conditions":"Gastric Cancer","enrollment":69},{"nctId":"NCT05508126","phase":"","title":"Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2021-11-01","conditions":"Gastric Cancer Stage","enrollment":222},{"nctId":"NCT02891447","phase":"PHASE2","title":"Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-09-01","conditions":"Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis","enrollment":24},{"nctId":"NCT06597227","phase":"PHASE4","title":"Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy","status":"RECRUITING","sponsor":"Guihua Wang","startDate":"2024-03-01","conditions":"Locally Advanced Gastric Cancer","enrollment":404},{"nctId":"NCT02969122","phase":"NA","title":"Treatment Strategy for Stage IV Gastric Cancer with Positive Peritoneal Cytology As the Only Non-curable Factor","status":"TERMINATED","sponsor":"Peking University","startDate":"2016-11","conditions":"Stomach Neoplasm","enrollment":59},{"nctId":"NCT06521541","phase":"NA","title":"Whole Course Multi-model Prehabilitation to Improve Clinical Outcome in Patients Undergoing Neoadjuvant Treatment Prior to Gastrectomy","status":"RECRUITING","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2024-06-01","conditions":"Gastric Cancer, Prehabilitation","enrollment":90},{"nctId":"NCT06472063","phase":"","title":"Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study","status":"RECRUITING","sponsor":"San Luigi Gonzaga Hospital","startDate":"2022-09-22","conditions":"Gastric Cancer","enrollment":684},{"nctId":"NCT06451211","phase":"PHASE2","title":"Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-05-17","conditions":"Stomach Neoplasms, Gastric Cancer, Linitis Plastica of Stomach","enrollment":53},{"nctId":"NCT06451393","phase":"","title":"Predicting Gastric Cancer Response to Chemo With Multimodal AI Model","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2013-02-01","conditions":"Gastric Cancer, Chemotherapy Effect","enrollment":500},{"nctId":"NCT04943484","phase":"","title":"ICG (Indocyanine Green) Imaging Fluorescence Technology in Surgical Treatment of Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Niguarda Hospital","startDate":"2022-01-01","conditions":"Gastric Cancer","enrollment":360},{"nctId":"NCT06419140","phase":"PHASE2","title":"Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy","status":"NOT_YET_RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2024-06-01","conditions":"Gastric Cancer","enrollment":138},{"nctId":"NCT04878783","phase":"","title":"Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Roma La Sapienza","startDate":"2019-12-20","conditions":"Gastric Cancer, Adenocarcinoma of the Stomach","enrollment":138},{"nctId":"NCT01882933","phase":"PHASE3","title":"D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2013-06","conditions":"Gastric Adenocarcinoma","enrollment":367},{"nctId":"NCT02509286","phase":"PHASE3","title":"Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital Schleswig-Holstein","startDate":"2016-01","conditions":"Esophageal Adenocarcinoma (UICC TNM7), Adenocarcinoma of the Esophagogastric Junction","enrollment":438},{"nctId":"NCT02931890","phase":"PHASE2","title":"Multicentric Randomised Trial for Resectable Gastric Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2017-12-21","conditions":"Gastric Cancer","enrollment":207},{"nctId":"NCT06365814","phase":"","title":"ERAS for Gastric Cancer Patients After NACT","status":"COMPLETED","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2023-10-01","conditions":"Gastric Cancer","enrollment":252},{"nctId":"NCT06295094","phase":"PHASE2","title":"The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.","status":"NOT_YET_RECRUITING","sponsor":"Odense University Hospital","startDate":"2024-09","conditions":"Gastric Cancer, Chemotherapy, Adjuvant, Peritoneal Metastases","enrollment":264},{"nctId":"NCT04597294","phase":"PHASE3","title":"Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2021-08-01","conditions":"Gastric Cancer","enrollment":600},{"nctId":"NCT06235164","phase":"","title":"The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer","status":"UNKNOWN","sponsor":"Fujian Medical University","startDate":"2019-01-01","conditions":"Locally Advanced Gastric Cancer","enrollment":585},{"nctId":"NCT04999332","phase":"PHASE2","title":"Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer","status":"UNKNOWN","sponsor":"National Cheng-Kung University Hospital","startDate":"2021-12-10","conditions":"Gastric Cancer, Gastric Adenocarcinoma, Effects of Chemotherapy","enrollment":58},{"nctId":"NCT04308837","phase":"PHASE2","title":"A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation","status":"UNKNOWN","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2018-12-03","conditions":"Gastric Cancer, Stomach Cancer","enrollment":29},{"nctId":"NCT06121700","phase":"PHASE2","title":"Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2023-01-01","conditions":"Adenocarcinoma, Stomach Neoplasm, Gastroesophageal-junction Cancer","enrollment":55},{"nctId":"NCT06118658","phase":"PHASE2","title":"Chemotherapy Sequential Tislelizumab After Radical Resection in Patients With dMMR/MSI-H or POLE/POLD1 Mutations","status":"NOT_YET_RECRUITING","sponsor":"China Medical University, China","startDate":"2023-11-01","conditions":"Gastric, Colorectal Adenocarcinoma","enrollment":30},{"nctId":"NCT04611997","phase":"PHASE3","title":"IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fujian Medical University","startDate":"2020-11-16","conditions":"Gastric Cancer, Lymph Node Metastases","enrollment":240},{"nctId":"NCT05318794","phase":"PHASE2","title":"Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"Imperial College London","startDate":"2023-11","conditions":"Gastric Cancer, Peritoneal Metastases, Chemotherapy Effect","enrollment":20},{"nctId":"NCT05264896","phase":"PHASE3","title":"Perioperative FLOT vs Adjuvant XELOX for CA Stomach","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2022-03-21","conditions":"Cancer of Stomach, Adenocarcinoma","enrollment":110},{"nctId":"NCT02995850","phase":"PHASE1, PHASE2","title":"A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2017-02-22","conditions":"Gastric Cancer With Peritoneal Metastasis (PCI<12)","enrollment":25},{"nctId":"NCT00003298","phase":"PHASE2","title":"Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer","status":"COMPLETED","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"1999-06-01","conditions":"Gastric Cancer","enrollment":39},{"nctId":"NCT04581447","phase":"PHASE3","title":"Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-01-07","conditions":"Diabetes, Bariatric Surgery, Metformin","enrollment":126},{"nctId":"NCT05541146","phase":"PHASE2","title":"Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis","status":"UNKNOWN","sponsor":"Instituto do Cancer do Estado de São Paulo","startDate":"2022-06-01","conditions":"Gastric Cancer, Peritoneal Carcinomatosis","enrollment":30},{"nctId":"NCT05728606","phase":"NA","title":"Robot-assisted D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers","status":"UNKNOWN","sponsor":"Hebei Medical University","startDate":"2023-01-20","conditions":"Gastric Cancer","enrollment":70},{"nctId":"NCT03603080","phase":"PHASE4","title":"Efficacy of Pharmacotherapy to Enhance Weight Loss Following Sleeve Gastrectomy","status":"TERMINATED","sponsor":"Hartford Hospital","startDate":"2019-03-01","conditions":"Obesity","enrollment":12},{"nctId":"NCT05723718","phase":"","title":"MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment","status":"RECRUITING","sponsor":"Medical University of Lublin","startDate":"2022-12-20","conditions":"Gastric Cancer, Gastric Adenocarcinoma, Malnutrition","enrollment":125},{"nctId":"NCT02191566","phase":"PHASE2","title":"S-1/Oxaliplatin for High Risk Patients Who Underwent Gastrectomy","status":"TERMINATED","sponsor":"Kangbuk Samsung Hospital","startDate":"2015-05","conditions":"Stomach Cancer","enrollment":8},{"nctId":"NCT05300945","phase":"PHASE2, PHASE3","title":"HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy","status":"NOT_YET_RECRUITING","sponsor":"Zhixin Cao","startDate":"2023-01-01","conditions":"Gastric Cancer, Peritoneal Metastases","enrollment":200},{"nctId":"NCT05594381","phase":"PHASE2","title":"A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2022-10","conditions":"Gastric Cancer","enrollment":90},{"nctId":"NCT04047004","phase":"PHASE1","title":"Adjuvant PIPAC in Gastric Cancer Patients","status":"COMPLETED","sponsor":"Michael Bau Mortensen","startDate":"2020-03-11","conditions":"Gastric Adenocarcinoma, Gastric Cancer","enrollment":20},{"nctId":"NCT04574245","phase":"","title":"Gastric Cancer Liver Metastasis Cohort of China","status":"UNKNOWN","sponsor":"Chinese PLA General Hospital","startDate":"2010-01-01","conditions":"Stomach Neoplasms, Neoplasm Metastasis","enrollment":3000},{"nctId":"NCT05468138","phase":"PHASE2","title":"PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2022-08-25","conditions":"MSI-H, PD-1 Immunotherapy, Gastric Cancer","enrollment":141},{"nctId":"NCT03001726","phase":"","title":"To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2017-01","conditions":"Gastric Cancer","enrollment":228},{"nctId":"NCT05230771","phase":"PHASE3","title":"Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"Fujian Medical University","startDate":"2022-04-01","conditions":"Metastatic Gastric Cancer, Surgery, Chemotherapy","enrollment":120},{"nctId":"NCT05270824","phase":"PHASE3","title":"Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma","status":"NOT_YET_RECRUITING","sponsor":"Fujian Medical University","startDate":"2022-03-01","conditions":"Advanced Gastric Carcinoma, CD8+ Tumor Infiltrating Lymphocytes, Neoadjuvant Immunotherapy","enrollment":120},{"nctId":"NCT05228743","phase":"NA","title":"Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer","status":"UNKNOWN","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2020-09-01","conditions":"Gastric Cancer","enrollment":180},{"nctId":"NCT05186402","phase":"","title":"Predictive Factors of Morbidity and Mortality and Overall Survival of Patients With Gastric Cancer : a Case Series","status":"COMPLETED","sponsor":"Sylvestre KABURA","startDate":"2016-01-01","conditions":"Gastric Cancer, Mortality of Gastric Cancer, Overall Survival of Patients With Gastric Cancer","enrollment":80},{"nctId":"NCT05125614","phase":"","title":"Gastric Cancer Survival Without Chemotherapy","status":"COMPLETED","sponsor":"Saint Vincent's Hospital, Korea","startDate":"2020-05-01","conditions":"Gastric Cancer","enrollment":342},{"nctId":"NCT05095467","phase":"PHASE2","title":"HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction","status":"NOT_YET_RECRUITING","sponsor":"Xuefei.Wang","startDate":"2021-10","conditions":"Stomach Neoplasms, Peritoneal Metastases","enrollment":157}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Gastrectomy+ chemotherapy","genericName":"Gastrectomy+ chemotherapy","companyName":"Japan Clinical Oncology Group","companyId":"japan-clinical-oncology-group","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Gastrectomy combined with chemotherapy removes the primary gastric tumor while systemic chemotherapy targets residual and metastatic cancer cells. Used for Locally advanced gastric cancer, Gastric adenocarcinoma amenable to curative resection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}